Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab (Q39725547)
Jump to navigation
Jump to search
scientific article published on July 2011
- Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer’s disease study cohorts from phase 3 trials of semagacestat and solanezumab
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab |
scientific article published on July 2011 |
|
Statements
1 reference
Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab (English)
1 reference
1 reference
Christopher Carlson
1 reference
Wahiba Estergard
1 reference
Joonmi Oh
1 reference
Joyce Suhy
1 reference
Eric Siemers
1 reference
Jerome Barakos
1 reference
1 July 2011
1 reference
1 reference
7
1 reference
4
1 reference
396-401
1 reference
Identifiers
1 reference
1 reference